Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer
Closed
Phase 2
This trial is looking at using a new drug called dasatinib with gemcitabine for pancreatic cancer that has spread into the surrounding tissue ().
Recruitment start: 26 August 2011
Recruitment end: 15 November 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Otsuka Pharmaceutical Development & Commercialization Inc
Last reviewed: 23 Nov 2015
CRUK internal database number: 8646
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
